MD970143A - Compoziţie farmaceutică - Google Patents

Compoziţie farmaceutică

Info

Publication number
MD970143A
MD970143A MD97-0143A MD970143A MD970143A MD 970143 A MD970143 A MD 970143A MD 970143 A MD970143 A MD 970143A MD 970143 A MD970143 A MD 970143A
Authority
MD
Moldova
Prior art keywords
pharmaceutical composition
clamed
narcolepsy
harmless
particles
Prior art date
Application number
MD97-0143A
Other languages
English (en)
Russian (ru)
Inventor
Peter E. Grebow
Vincent Corvari
David Stong
Original Assignee
Cephalon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23240954&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MD970143(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cephalon, Inc. filed Critical Cephalon, Inc.
Publication of MD970143A publication Critical patent/MD970143A/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Paints Or Removers (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicinal Preparation (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Este revendicată compoziţia farmaceutică care conţine modafinil sub formă de particule de o anumită mărime, care este eficace şi inofensivă în tratamentul narcolepsiei, hipersomniei idiopatice şi altor forme similare de dereglare a somnului.
MD97-0143A 1994-10-06 1995-10-04 Compoziţie farmaceutică MD970143A (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/319,124 US5618845A (en) 1994-10-06 1994-10-06 Acetamide derivative having defined particle size
PCT/US1995/012944 WO1996011001A1 (en) 1994-10-06 1995-10-04 Modafinil having defined particle size

Publications (1)

Publication Number Publication Date
MD970143A true MD970143A (ro) 1998-12-31

Family

ID=23240954

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0143A MD970143A (ro) 1994-10-06 1995-10-04 Compoziţie farmaceutică

Country Status (34)

Country Link
US (2) US5618845A (ro)
EP (3) EP1088549B1 (ro)
JP (1) JP2915146B2 (ro)
KR (1) KR100249360B1 (ro)
AT (3) ATE188607T1 (ro)
AU (1) AU703087B2 (ro)
BG (1) BG62952B1 (ro)
BR (1) BR9509257A (ro)
CA (2) CA2201967C (ro)
CZ (1) CZ291700B6 (ro)
DE (3) DE69535786D1 (ro)
DK (3) DK0966962T3 (ro)
EE (1) EE9700082A (ro)
ES (3) ES2156457T3 (ro)
FI (1) FI121454B (ro)
GB (1) GB2293103B (ro)
GR (2) GR3033152T3 (ro)
HK (1) HK1003561A1 (ro)
HU (1) HU226411B1 (ro)
IS (1) IS1987B (ro)
LT (1) LT4303B (ro)
LV (1) LV11852B (ro)
MD (1) MD970143A (ro)
MX (1) MX9602176A (ro)
NO (1) NO318818B1 (ro)
NZ (1) NZ295869A (ro)
PL (1) PL181523B1 (ro)
PT (3) PT1088549E (ro)
RO (1) RO118928B1 (ro)
RU (1) RU2287987C2 (ro)
SI (1) SI9520106B (ro)
SK (1) SK283632B6 (ro)
UA (1) UA42023C2 (ro)
WO (1) WO1996011001A1 (ro)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA71629C2 (en) * 1999-08-03 2004-12-15 Lilli Icos Llc Composition containing free drug particulate form of ?-carboline (variants), method for its manufacture (variants), and method for treating sexual dysfunction
US6821975B1 (en) 1999-08-03 2004-11-23 Lilly Icos Llc Beta-carboline drug products
US6346548B1 (en) 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6455588B1 (en) 1999-08-20 2002-09-24 Cephalon, Inc. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
FR2804322B1 (fr) * 2000-01-31 2002-04-19 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament destine a corriger les troubles de la vigilance associes aux myopathies
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6492396B2 (en) 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
DK1787980T3 (da) * 2000-07-27 2010-04-26 Teva Pharma Krystallint og rent modafinil og fremgangsmåde til atfremstille dette
DE60137069D1 (de) * 2000-10-11 2009-01-29 Cephalon Inc Arzneizusammensetzungen enthaltend modafinilverbindungen
US6489363B2 (en) * 2000-10-11 2002-12-03 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US6919378B2 (en) * 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
IL155322A0 (en) * 2000-10-11 2003-11-23 Cephalon Inc Compositions comprising modafinil compounds
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US7141555B2 (en) 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
IL158959A (en) * 2001-05-25 2010-06-30 Cephalon Inc Solid pharmaceutical formulations comprising modafinil
US7576133B2 (en) 2002-03-11 2009-08-18 Carl Henry Lawyer Methods and compositions for nasal administration of modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
MY137846A (en) * 2002-07-08 2009-03-31 Ranbaxy Lab Ltd Processes for the preparation of oral dosage formulations of modafinil
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
AU2003247001A1 (en) * 2002-07-25 2004-02-16 Ranbaxy Laboratories Limited Processes for the preparation of oral dosage formulations of modafinil
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
CA2420180A1 (en) * 2003-02-28 2004-08-28 Bernard Charles Sherman Tablets comprising modafinil
WO2004082630A2 (en) * 2003-03-17 2004-09-30 Neurohealing Pharmaceuticals, Inc. High potency dopaminergic treatment of neurological impairment associated with brain injury
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
ES2330321T3 (es) * 2003-05-16 2009-12-09 Cephalon France Procedimiento de sintesis de modafinilo.
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US20050137264A1 (en) * 2003-12-22 2005-06-23 Patel Ashish A. Modafinil compositions
EP2292213A1 (en) 2004-02-06 2011-03-09 Cephalon, Inc. Compositions comprising a polymorphic form of armodafinil
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
GT200600008A (es) * 2005-01-18 2006-08-09 Formulacion de compresion directa y proceso
US20090123545A1 (en) * 2005-07-21 2009-05-14 Ron Eyal S Rapid Onset and Short Term Modafinil Compositions and Methods of Use Thereof
EP1951197A4 (en) * 2005-11-10 2011-12-21 Alphapharm Pty Ltd METHOD OF CHECKING THE PARTICLE SIZE
MX2009000391A (es) * 2006-07-12 2009-06-30 Elan Pharma Int Ltd Formulación de modafinilo en forma de nano-partículas.
CA2660565C (en) * 2006-08-14 2012-10-09 Neurohealing Pharmaceuticals, Inc. Modafinil-based treatment for premature ejaculation
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
WO2008074097A1 (en) 2006-12-21 2008-06-26 Alphapharm Pty Ltd Pharmaceutical compound and composition
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
US20110206770A1 (en) * 2008-07-25 2011-08-25 Alphapharm Pty. Ltd. Atovaquone with a particle size diameter range (d90) of greater than 3 microns to about 10 microns
US20100036164A1 (en) * 2008-08-06 2010-02-11 Srinivas Areveli Preparation of armodafinil form i
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
FR2987267B1 (fr) * 2012-02-28 2015-01-16 Debregeas Et Associes Pharma Application du modafinil dans le traitement de substitution des cacainomanes
FR2987266B1 (fr) * 2012-02-28 2014-12-19 Debregeas Et Associes Pharma Procede d'obtention d'une composition pharmaceutique a base de modafinil, composition pharmaceutique ainsi obtenue et son application
FR2987265B1 (fr) * 2012-02-28 2014-02-28 Debregeas Et Associes Pharma Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
IT1130924B (it) * 1980-03-06 1986-06-18 Secifarma Spa Procedimento per la preparazione di spironolattone micronizzato
FR2551761B1 (fr) * 1983-09-12 1985-10-18 Poudres & Explosifs Ste Nale Resines polystyrylpyridines a tenacite amelioree et materiau composite comprenant ces resines
US4600614A (en) * 1983-09-12 1986-07-15 The Dow Chemical Company High-frequency heatable plastics
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
DE3720493A1 (de) * 1987-06-20 1989-01-26 Nattermann A & Cie Arzneizubereitungen mit mikronisierten ebselen-kristallen
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
FR2697162B1 (fr) * 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
FR2702968B1 (fr) * 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
DK0692061T3 (da) 1993-04-05 2003-01-06 Sds Pty Ltd Slagboringsforbedringer
FR2706767B1 (ro) * 1993-06-22 1995-09-08 Lafon Labor
FR2708201B1 (fr) * 1993-06-30 1995-10-20 Lafon Labor Utilisation de dérivés d'acétamide pour la fabrication de médicaments.
US5493146A (en) 1994-07-14 1996-02-20 Vlsi Technology, Inc. Anti-fuse structure for reducing contamination of the anti-fuse material

Also Published As

Publication number Publication date
NO971541L (no) 1997-06-04
GB2293103B (en) 1997-05-07
LV11852B (lv) 1998-03-20
SI9520106A (sl) 1998-02-28
PL181523B1 (en) 2001-08-31
FI971417A0 (fi) 1997-04-04
CZ291700B6 (cs) 2003-05-14
EE9700082A (et) 1997-10-15
EP0731698A1 (en) 1996-09-18
DE69520161T2 (de) 2001-08-02
ATE400260T1 (de) 2008-07-15
GR3035451T3 (en) 2001-05-31
DE69514497D1 (de) 2000-02-17
GR3033152T3 (en) 2000-08-31
WO1996011001A1 (en) 1996-04-18
SK283632B6 (sk) 2003-11-04
AU703087B2 (en) 1999-03-18
HK1003561A1 (en) 1998-10-30
GB9524328D0 (en) 1996-01-31
LT97060A (en) 1997-10-27
BG101389A (en) 1997-12-30
EP1088549B1 (en) 2008-07-09
IS1987B (is) 2005-02-15
PT731698E (pt) 2000-05-31
HUT77778A (hu) 1998-08-28
GB2293103A (en) 1996-03-20
CA2382275C (en) 2003-12-16
CA2382275A1 (en) 1996-04-18
CZ103297A3 (en) 1997-09-17
IS4451A (is) 1997-03-24
ATE188607T1 (de) 2000-01-15
US5618845A (en) 1997-04-08
LV11852A (lv) 1997-10-20
BR9509257A (pt) 1998-07-07
SK44597A3 (en) 1997-09-10
DK1088549T3 (da) 2008-11-17
NZ295869A (en) 1998-02-26
HK1024625A1 (en) 2000-10-20
RO118928B1 (ro) 2004-01-30
ES2156457T3 (es) 2001-06-16
LT4303B (lt) 1998-03-25
ATE199216T1 (de) 2001-03-15
MX9602176A (es) 1997-05-31
PT966962E (pt) 2001-06-29
EP0731698B1 (en) 2000-01-12
FI121454B (fi) 2010-11-30
ES2308960T3 (es) 2008-12-16
DE69514497T2 (de) 2000-08-10
DK0731698T3 (da) 2000-05-08
BG62952B1 (bg) 2000-12-29
AU3951495A (en) 1996-05-02
PT1088549E (pt) 2008-09-23
CA2201967C (en) 2002-12-10
NO318818B1 (no) 2005-05-09
EP0966962A1 (en) 1999-12-29
DE69535786D1 (de) 2008-08-21
HU226411B1 (en) 2008-11-28
FI971417L (fi) 1997-04-04
HK1034676A1 (en) 2001-11-02
UA42023C2 (uk) 2001-10-15
NO971541D0 (no) 1997-04-04
JPH09511754A (ja) 1997-11-25
USRE37516E1 (en) 2002-01-15
RU2287987C2 (ru) 2006-11-27
EP0966962B1 (en) 2001-02-21
ES2142499T3 (es) 2000-04-16
JP2915146B2 (ja) 1999-07-05
DK0966962T3 (da) 2001-03-19
EP1088549A1 (en) 2001-04-04
PL319480A1 (en) 1997-08-04
SI9520106B (sl) 2003-12-31
CA2201967A1 (en) 1996-04-18
DE69520161D1 (de) 2001-03-29
KR100249360B1 (ko) 2000-04-01

Similar Documents

Publication Publication Date Title
HUP9801577A3 (en) Synergistic herbicidal composition of s-metolachlor and its use
HU9303218D0 (en) Application of atp-depended protease and its inhibitor for treatment of cachexy and amyotrophia
EP0611302A4 (en) METHODS AND COMPOSITIONS FOR TREATING ALLERGIC REACTIONS.
IL112205A0 (en) Curcumin, analogues of curcumin and novel uses thereof
BG101389A (en) Modafinil having defined particle size
IL126592A0 (en) The use of mmp-13 selective inhibitors for the treatment of osteoarthritis and other mmp-mediated disorders
ID27937A (id) Penggunaan komposisi yang mengandung formoterol dan budesonida untuk pencegahan atau pengobatan kondisi asma yang akut
PL330496A1 (en) Methods of and compositions for treating and preventing tumours, disorders associated with tumours as well as cachexy
HU9503702D0 (en) Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin
IL116505A0 (en) Compounds with progesterone-antagonistic and antiestrogenic action and the use thereof for the manufacture of pharmaceutical agents
IL134937A0 (en) Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
IL115766A0 (en) Composition and treatment for multiple sclerosis
HU9602798D0 (en) Benzamide derivative, compositions containing said derivative and use thereof
ZA966063B (en) Synergistic herbicidal composition and method of use thereof.
PL344011A1 (en) Process for the preparation of sertraline and its 1,r-stereoisomer
IL116101A0 (en) Benzamide its preparation and pharmaceutical compositions containing it
IL111554A (en) Methods and compositions for hair treatment
PL328833A1 (en) Application of carbonic anhydrase inhibitor in treating the macula oedema
PL332603A1 (en) Application of 1-hydroxy-2-pyridinones in treating seborrhoic dermatitis
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
PL308245A1 (en) Application of 4'-iodo-4'-desoxydoxorubicine in treating amyloidosis
BR9500886A (pt) Composições com efeito regulador de crescimento e método para o tratamento de culturas
PL337665A1 (en) (s) 2-methylamine-2-phenyl-n-butyl-3,4,5-trimethoxybezoate and application thereof in treating long-lasting pains
GB2289277B (en) Taxane compounds and uses thereof
GB9402886D0 (en) The treatment of gaseous substances